{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:17:48Z","timestamp":1793089068619,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ecl.2024.05.004","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T19:51:47Z","timestamp":1718740307000},"page":"409-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prolactinomas"],"prefix":"10.1016","volume":"53","author":[{"given":"Catherine D.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana G.","family":"Ioachimescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ecl.2024.05.004_bib1","doi-asserted-by":"crossref","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","article-title":"The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new","volume":"33","author":"Chanson","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.004_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ecl.2024.05.004_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clineuro.2018.11.024","article-title":"Fertility after transsphenoidal surgery in patients with prolactinomas: A meta-analysis","volume":"176","author":"Lamba","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"10.1016\/j.ecl.2024.05.004_bib4","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jocn.2015.03.058","article-title":"Update on prolactinomas. Part 1: Clinical manifestations and diagnostic challenges","volume":"22","author":"Wong","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.004_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/S0098858800006535","article-title":"Recent advances in medically assisted conception: legal, ethical and social issues","volume":"17","author":"Knoppers","year":"1991","journal-title":"Am J Law Med"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.004_bib6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.fertnstert.2009.12.017","article-title":"Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility","volume":"94","author":"Souter","year":"2010","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.ecl.2024.05.004_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0011-5029(82)90628-9","article-title":"Hyperprolactinemic disorders","volume":"28","author":"Molitch","year":"1982","journal-title":"Dis Mon"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.004_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cen.13156","article-title":"The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS)","volume":"86","author":"Soto-Pedre","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2024.05.004_bib9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1210\/js.2017-00328","article-title":"Hypothalamic-pituitary-ovarian axis reactivation by kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea","volume":"1","author":"Millar","year":"2017","journal-title":"Journal of the Endocrine Society"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.004_bib10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/jne.12223","article-title":"Prolactin regulation of kisspeptin neurones in the mouse brain and its role in the lactation-induced suppression of kisspeptin expression","volume":"26","author":"Brown","year":"2014","journal-title":"J\u00a0Neuroendocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2024.05.004_bib11","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1172\/JCI63937","article-title":"Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration","volume":"122","author":"Sonigo","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"5978","key":"10.1016\/j.ecl.2024.05.004_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bmj.3.5978.274","article-title":"An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea","volume":"3","author":"Glass","year":"1975","journal-title":"Br Med J"},{"issue":"5807","key":"10.1016\/j.ecl.2024.05.004_bib13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/290600a0","article-title":"Prolactin inhibits oestrogen synthesis in the ovary","volume":"290","author":"Dorrington","year":"1981","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.004_bib14","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1210\/jcem-54-6-1246","article-title":"Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17\u03b2-estradiol in the human ovary","volume":"54","author":"Demura","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.004_bib15","first-page":"486","article-title":"Prolactin hypersecretion and short luteal phase defects","volume":"47","author":"Corenblum","year":"1976","journal-title":"Obstet Gynecol"},{"issue":"7953","key":"10.1016\/j.ecl.2024.05.004_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(76)91343-X","article-title":"Hyperprolactinaemia and luteal insufficiency","volume":"1","author":"Sepp\u00e4l\u00e4","year":"1976","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ecl.2024.05.004_bib17","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A\u00a0Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea","volume":"331","author":"Webster","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.004_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00002018-199614040-00003","article-title":"A\u00a0comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation","volume":"14","author":"Webster","year":"1996","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.004_bib19","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1210\/jc.2009-2605","article-title":"Individualized High-Dose Cabergoline Therapy for Hyperprolactinemic Infertility in Women with Micro- and Macroprolactinomas","volume":"95","author":"Ono","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.004_bib20","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","article-title":"Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis","volume":"105","author":"Zamanipoor","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"11","key":"10.1016\/j.ecl.2024.05.004_bib21","first-page":"21557","article-title":"Effect of transsphenoidal surgery and standard care on fertility related indicators of patients with prolactinomas during child-bearing period","volume":"8","author":"Yan","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.004_bib22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0002-9378(77)90594-4","article-title":"Pattern of increase in circulating prolactin levels during human gestation","volume":"129","author":"Rigg","year":"1977","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.004_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12884-016-0937-5","article-title":"Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study","volume":"16","author":"Schock","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.004_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiology.181.2.1924800","article-title":"Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging","volume":"181","author":"Elster","year":"1991","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.004_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12020-017-1438-7","article-title":"Prolactinoma through the female life cycle","volume":"59","author":"Cocks Eschler","year":"2018","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.004_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","article-title":"Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women","volume":"73","author":"Lebbe","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.004_bib27","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.004_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11102-019-01008-z","article-title":"A\u00a0Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas","volume":"23","author":"Sant\u2019 Anna","year":"2020","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.004_bib29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1530\/acta.0.1110452","article-title":"Women with prolactinoma\u2013effect of pregnancy and lactation on serum prolactin and on tumour growth","volume":"111","author":"Holmgren","year":"1986","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2024.05.004_bib30","article-title":"Challenges of Pituitary Apoplexy in Pregnancy","volume":"12","author":"Gheorghe","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.004_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/EJE-21-0145","article-title":"Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature","volume":"185","author":"Kuhn","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.ecl.2024.05.004_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/09513590.2021.1938527","article-title":"Pituitary apoplexy of a giant prolactinoma during pregnancy","volume":"37","author":"Khaldi","year":"2021","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.004_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1210\/jcem-48-1-9","article-title":"A\u00a0Pregnancy in an Acromegalic Woman during Bromocriptine Treatment: Effects on Growth Hormone and Prolactin in the Maternal, Fetal, and Amniotic Compartments","volume":"48","author":"BIGAZZI","year":"1979","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.ecl.2024.05.004_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/2046-4053-1-33","article-title":"Treatment of hyperprolactinemia: a systematic review and meta-analysis","volume":"1","author":"Wang","year":"2012","journal-title":"Syst Rev"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.004_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ecl.2019.05.004","article-title":"Pituitary Tumors in Pregnancy","volume":"48","author":"Huang","year":"2019","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.004_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11102-005-5083-4","article-title":"Prolactinomas and Pregnancy","volume":"8","author":"Bronstein","year":"2005","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.004_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000180100","article-title":"Follow-up of children born of bromocriptine-treated mothers","volume":"22","author":"Raymond","year":"1985","journal-title":"Horm Res"},{"issue":"17","key":"10.1016\/j.ecl.2024.05.004_bib38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/BF01727477","article-title":"Bromocriptine in pregnancy: safety aspects","volume":"65","author":"Krupp","year":"1987","journal-title":"Klin Wochenschr"},{"issue":"8","key":"10.1016\/j.ecl.2024.05.004_bib39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9378(83)90968-7","article-title":"Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas","volume":"146","author":"Konopka","year":"1983","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ecl.2024.05.004_bib40","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1055\/s-0043-112861","article-title":"Pregnancy and tumor outcomes in women with prolactinoma","volume":"125","author":"Araujo","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.004_bib41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0890-6238(96)00134-7","article-title":"Reproductive toxicity of cabergoline in mice, rats, and rabbits","volume":"10","author":"Beltrame","year":"1996","journal-title":"Reprod Toxicol"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.004_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11102-010-0243-6","article-title":"Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature","volume":"13","author":"Stalldecker","year":"2010","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.004_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00404-014-3210-z","article-title":"Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database","volume":"290","author":"Hurault-Delarue","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.004_bib44","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-21-0462","article-title":"ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy","volume":"185","author":"Luger","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.004_bib45","first-page":"425","article-title":"Prolactin-producing microadenomas in pregnancy","volume":"62","author":"DIVERS","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.004_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1701-2163(15)30612-5","article-title":"RETIRED: the use of magnetic resonance imaging in the obstetric patient","volume":"36","author":"Patenaude","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ecl.2024.05.004_bib47","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s00330-004-2583-y","article-title":"The use of iodinated and gadolinium contrast media during pregnancy and lactation","volume":"15","author":"Webb","year":"2005","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.004_bib48","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1097\/AOG.0000000000002355","article-title":"Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.004_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1753495X15598917","article-title":"Pituitary apoplexy in pregnancy: A case series and literature review","volume":"8","author":"Grand'Maison","year":"2015","journal-title":"Obstet Med"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.004_bib50","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0015-0282(16)59182-1","article-title":"Relationship between the methods of treatment for prolactinomas and the puerperal lactation","volume":"47","author":"Ikegami","year":"1987","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.ecl.2024.05.004_bib51","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1210\/clinem\/dgad174","article-title":"Approach to the Patient With Prolactinoma","volume":"108","author":"Auriemma","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.004_bib52","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12370","article-title":"Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients","volume":"80","author":"Domingue","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.004_bib53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/ajo.13070","article-title":"An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists","volume":"60","author":"O'Sullivan","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"06","key":"10.1016\/j.ecl.2024.05.004_bib54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/a-1468-4608","article-title":"Outcomes of Patients with Macroprolactinoma Desiring Pregnancy: Follow-Up to 23 Years from a Single Center","volume":"53","author":"Tanrikulu","year":"2021","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2024.05.004_bib55","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11102-014-0617-2","article-title":"Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis","volume":"18","author":"Hu","year":"2015","journal-title":"Pituitary"},{"issue":"7","key":"10.1016\/j.ecl.2024.05.004_bib56","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1210\/jc.2008-2103","article-title":"Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy","volume":"94","author":"Kharlip","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metabol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T05:26:41Z","timestamp":1722317201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852924000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0889852924000343"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2024.05.004","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolactinomas","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2024.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}